Poland· PL-100077330
Dipeptiven
A aminosäuren product containing n(2) - l - alanylum - gutaminum, registered in Poland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Aminosäuren is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Aminosäuren · ATC B05BA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- N(2) - L - alanylum - gutaminum
- Manufacturer
- Fresenius Kabi Deutschland GmbH
- Country
- Poland (PL)
- ATC code
- B05BA01
- ATC class
- Aminosäuren
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990733019
- gtin05909990733026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for aminosäuren.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aminosäuren · interactions on record
4 records
- 4 moderate
Most severe, free to view
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- MetamfetamineN06BA03moderate
- LisdexamfetamineN06BA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B05BA01
Aminosäuren, as other registers publish it.
- Canada20% PROSOLBAXTER CORPORATION
- FinlandAminessPfizer Health Ab
- PolandAminomix 1 NovumFresenius Kabi Deutschland GmbH
- DenmarkAminoplasmalB. Braun Melsungen
- FinlandAminoplasmalB. Braun Melsungen AG
- PolandAminoplasmal 15%B. Braun Melsungen AG
- CzechiaAMINOPLASMAL 15%B. Braun Melsungen AG, Melsungen
- CzechiaAMINOPLASMAL 15%B. Braun Melsungen AG, Melsungen
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba8625ce-6571-4ceb-b7e8-70f5c21265d5 GET /v1/drugs/ba8625ce-6571-4ceb-b7e8-70f5c21265d5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "200 mg/ml",
"packaging": "05909990733019 ¦ Lz ¦ 11648\n1 butelka 50 ml\n05909990733026 ¦ Lz ¦ 11649\n1 butelka 100 ml",
"substance": "N(2)-L-alanyl-glutamine 200 mg/ml",
"common_name": "N(2) - L - alanylum - gutaminum",
"pl_product_id": "100077330",
"pozwolenie_nr": "07330",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about aminosäuren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.